Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Littleton, CO, US. The stock last traded at $0.29, down 7.44% on the session, giving a market capitalisation of $4.0M. On trailing twelve-month figures it carries a trailing P/E of -0.13, a net margin of -128.4%. Its beta of 6.09 implies it has historically moved more than the broad market.
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Vivos Therapeutics, Inc. is most often compared with the following Healthcare names: